)
Fresenius (FRE) investor relations material
Fresenius Credit presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company structure and business overview
Streamlined operations focus on Fresenius Kabi (pharma, biopharma, nutrition, MedTech) and Fresenius Helios (Europe’s leading private healthcare provider).
Fresenius Kabi leads globally in IV drugs and parenteral nutrition, with strong positions in MedTech and biopharma.
Fresenius Helios is the top hospital provider in Europe, with significant market shares in Germany and Spain.
Financial performance and growth
FY 2025 group revenue reached €22.6bn, with 7% organic growth and EBIT of €2.6bn, up 6%.
Core EPS grew 12% to €2.87, supported by strong operating results and reduced interest expenses.
Net debt/EBITDA improved to 2.7x, reflecting strong cash flow and deleveraging.
Q4 2025 saw 9% organic revenue growth and 13% EBIT growth, with a 12.1% EBIT margin.
Strategic initiatives and innovation
Biopharma launches (e.g., tocilizumab, ustekinumab, denosumab) drive revenue and margin expansion.
Digital transformation in Helios includes AI-based clinical decision support and digital patient engagement platforms.
Portfolio rejuvenation and new product launches contributed over €500m in revenue and >20% EBIT margin in FY 2025.
- Portfolio focus and innovation drive growth across healthcare, nutrition, and MedTech segments.FRE
44th Annual J.P. Morgan Healthcare Conference13 Apr 2026 - FY 2025 delivered robust growth and margin expansion, with a positive outlook for 2026.FRE
Q4 20258 Apr 2026 - Resilient global healthcare group posts solid Q2 2020 results, navigating COVID-19 challenges.FRE
Berenberg & Goldman Sachs 9th German Corporate Conference presentation11 Feb 2026 - Solid sales growth in Q2 2022 offset by profit declines amid labor and inflation headwinds.FRE
Morgan Stanley 20th Annual Global Healthcare Conference presentation11 Feb 2026 - Q1/24 delivered strong growth, outlook raised, and portfolio streamlined for higher quality earnings.FRE
Stifel European Healthcare Summit presentation11 Feb 2026 - Raised 2024 outlook with strong growth in pharma and hospital operations, emphasizing efficiency.FRE
SdK Anlegerforum presentation11 Feb 2026 - Q2/24 delivered robust growth, margin expansion, and accelerated transformation progress.FRE
Berenberg Seminar presentation11 Feb 2026 - Q3/24 delivered robust growth, margin expansion, and an upgraded FY/24 outlook.FRE
Berenberg European Conference presentation11 Feb 2026 - Transformation, innovation, and biosimilars drive growth and margin expansion.FRE
43rd Annual J.P. Morgan Healthcare Conference11 Feb 2026
Next Fresenius earnings date
Next Fresenius earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage